How Peptides Work
Peptides are short chains of amino acids — typically 2 to 50 — that act as biological messengers. This page explains, in plain language, what peptides do in the body, why the way they are delivered matters, and how to judge the strength of the evidence behind any given peptide.
What is a peptide?
Proteins are large, folded chains of amino acids. Peptides are much shorter fragments of the same building blocks. Because they are small and specific, many peptides work like keys that fit particular locks on the surface of cells, switching biological processes on or off. Your body already makes thousands of them — insulin, oxytocin, and many hormones are peptides.
The peptides discussed on this site are synthetic versions of naturally occurring signaling molecules, or close analogs designed to be more stable or longer-acting.
How peptides signal in the body
Most therapeutic peptides work by binding to a receptor — a protein on or inside a cell — and triggering a downstream cascade of effects. A few illustrative examples:
- GLP-1 receptor agonists (such as semaglutide and tirzepatide) mimic the gut hormone GLP-1, binding its receptor to slow gastric emptying, increase insulin release, and reduce appetite.
- Growth-hormone secretagogues (such as sermorelin, CJC-1295, and ipamorelin) prompt the pituitary gland to release the body's own growth hormone rather than replacing it directly.
- Regenerative and cytoprotective peptides (such as BPC-157) are studied largely in animals for effects on new blood-vessel formation (angiogenesis) and tissue repair.
The specificity of receptor binding is why peptides can have powerful, targeted effects — and also why small changes in structure or dose can matter a great deal.
Why delivery and stability matter
Peptides are fragile. The digestive tract is designed to break protein down into amino acids, so most peptides taken as a pill are destroyed before they reach the bloodstream. This is why the majority of research peptides are studied as injections, and why an orally available peptide (such as newer oral GLP-1 formulations) is considered a notable pharmaceutical achievement.
Stability also shapes how long a peptide lasts in the body. Chemical modifications can extend a peptide's half-life from minutes to days, which is the difference between a molecule that is impractical and one that can be dosed weekly.
How to read the evidence
Not all evidence is equal. When you see a claim about a peptide, it helps to know where on the following ladder it sits:
- Laboratory (in vitro) studies — effects observed in cells or a test tube. Useful for mechanism, but far from proof of benefit in people.
- Animal studies — effects in mice, rats, or other models. Many peptides look impressive here; most never replicate the same way in humans.
- Human clinical trials — the standard for establishing that something is safe and effective in people, ideally randomized and controlled.
A large share of the peptides discussed online rest almost entirely on the first two rungs. That does not make them worthless — it makes them promising and unproven, which is a very different thing from proven. Throughout this site we try to label where a claim sits on this ladder rather than blurring the line.
Why regulatory status is part of the picture
A peptide's legal and regulatory status is not a detail — it often reflects how much human safety and efficacy data exists. Some peptides are FDA-approved medicines with extensive trial data; others are available only as research chemicals with little human evidence and no manufacturing oversight. Before considering any peptide, it is worth understanding which category it falls into. See our Legal & Safety overview for the current U.S. regulatory landscape.
Educational only
This page is general education, not medical advice. It does not create a doctor–patient relationship. Many peptides discussed here are not approved for human use. Talk with your own physician before making any decision about your health.